Metformin enhances the survival ability of ovarian granulosa cells in polycystic ovary syndrome by promoting LINC00548 to suppress androgen receptor/klotho pathway

Documents similaires

• The impact of androgens on pregnancy and fetal outcomes in patients with polycystic ovary syndrome
  par: Ömer Tammo, et autres
  Publié: (2025)
• Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH ‐ MoM and ovarian sensitivity index
  par: Yoo Ra Ko, et autres
  Publié: (2024)
• Impact of short‐term ketogenic diet on sex hormones and glucose‐lipid metabolism in overweight or obese patients with polycystic ovary syndrome
  par: Meng Li, et autres
  Publié: (2024)
• Role of the mitophagy‐apoptosis axis in the pathogenesis of polycystic ovarian syndrome
  par: Hiroshi Kobayashi, et autres
  Publié: (2024)
• Cut‐off value for anti‐Müllerian hormone in the diagnostic criteria for polycystic ovary syndrome in the Japanese population
  par: Hiroki Noguchi, et autres
  Publié: (2024)